Article
Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite.
Department of Medical Oncology, Vrije Universiteit Medical Centre, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands.
Journal of Biological Chemistry (impact factor:
4.77).
01/2002;
276(51):48066-76.
DOI:10.1074/jbc.M106282200
pp.48066-76
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Hydrogen peroxide mediates arsenite activation of p70(s6k) and extracellular signal-regulated kinase.
[show abstract] [hide abstract]
ABSTRACT: To define the mechanism of arsenite-induced tumor promotion, we examined the role of reactive oxygen species (ROS) in the signaling pathways of cells exposed to arsenite. Arsenite treatment resulted in the persistent activation of p70(s6k) and extracellular signal-regulated kinase 1/2 (ERK1/2) which was accompanied by an increase in intracellular ROS production. The predominant produced appeared to be H(2)O(2), because the arsenite-induced increase in dichlorofluorescein (DCF) fluorescence was completely abolished by pretreatment with catalase but not with heat-inactivated catalase. Elimination of H(2)O(2) by catalase or N-acetyl-L-cysteine inhibited the arsenite-induced activation of p70(s6k) and ERK1/2, indicating the possible role of H(2)O(2) in the arsenite activation of the p70(s6k) and the ERK1/2 signaling pathways. A specific inhibitor of p70(s6k), rapamycin, and calcium chelators significantly blocked the activation of p70(s6k) induced by arsenite. While the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY294002 completely abrogated arsenite activation of p70(s6k), ERK1/2 activation by arsenite was not affected by these inhibitors, indicating that H(2)O(2) might act as an upstream molecule of PI3K as well as ERK1/2. Consistent with these results, none of the inhibitors impaired H(2)O(2) production by arsenite. DNA binding activity of AP-1, downstream of ERK1/2, was also inhibited by catalase, N-acetyl-L-cysteine, and the MEK inhibitor PD98059, which significantly blocked arsenite activation of ERK1/2. Taken together, these studies provide insight into mechanisms of arsenite-induced tumor promotion and suggest that H(2)O(2) plays a critical role in tumor promotion by arsenite through activation of the ERK1/2 and p70(s6k) signaling pathways.Experimental Cell Research 11/2003; 290(1):144-54. · 3.58 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
arsenite induces VEGF mRNA
arsenite-induced VEGF mRNA
general phenomenon
glutathione content
HIF-1alpha protein expression
human ovarian cancer cells
hypoxia-inducible Factor 1
mannitol attenuated arsenite-induced ROS production
OVCAR-3 cells
Pretreatment
protein levels
reactive oxygen species
Recent evidence
ROS inhibitors catalase
ROS production
thiol-sensitive mechanism
vascular endothelial growth factor
VEGF expression
VEGF mRNA
VEGF mRNA expression